Enhancing the Efforts of Advocacy Organizations
We work with partners globally to strengthen advocacy around disease prevention.
This week is “UN Week” which marks the annual United Nations General Assembly meeting in New York. Top leaders from around the world have descended upon NY to discuss many pressing issues on the global agenda, including the SDG goals and improving health worldwide.
With an estimated 37 million people currently living with HIV globally and 2.1 million people becoming newly infected each year, Johnson & Johnson stands united with the global community to fight HIV and care for those infected, and impacted.
DREAMS partners announce $85 million innovation challenge focused on solutions for reducing HIV infections
Johnson & Johnson issued a call for innovative ideas to reduce HIV infections in adolescent girls and young women in 10 sub-Saharan African countries as part of the DREAMS Innovation Challenge, supported by PEPFAR.
Johnson & Johnson announced a global partnership with Save the Children to support its core mission to improve newborn survival.
Johnson & Johnson announced it has joined more than 80 companies and organizations in signing the Declaration on Combating Antimicrobial Resistance, an industry-wide call to action that outlines how industry and governments can work together to support sustained innovation to address this growing problem.
Bloomberg reports on the industry-wide partnership to accelerate the development of drugs and diagnostics to help fight antimicrobial resistance.
Janssen and USAID entered into a new Memorandum of Understanding, as part of the U.S Government’s National Action Plan for combatting multi-drug resistant tuberculosis (MDR-TB), agreeing to expand patient access to novel MDR-TB therapies and increase funding for program partners.
Johnson & Johnson leadership reflects on a trip to South Africa where they met Chandre Heaton, a young woman who overcame XDR-TB.
Janssen leaders urged consideration of a special framework for innovation in antibiotics research and development at a congressional hearing.
Johnson & Johnson Vice President of Innovation, Global Public Health and Science Policy Communication, Seema Kumar shares her key highlights from the Global Fund Replenishment Conference to Fight HIV, Tuberculosis and Malaria.
Johnson & Johnson partnered with social action platform Global Citizen to elevate the global importance of strong public health programs.
Learn more about key themes related to global public health and STEM education that emerged at the 2016 World Economic Forum in Davos, Switzerland.
Learn about Johnson & Johnson’s commitment to improve the health of women and children in five key areas.